skip to main content

Content language

Contact us: CRM@email.irandoc.ac.ir

Concept information

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > carboxamide > peptide > (3r,6r,9s,12r,15r)-3-(1h-indol-3-ylmethyl)-15-(2-methylpropyl)-6,9,12-tri(propan-2-yl)-1,4,7,10,13,16,19-heptazacyclodocosane-2,5,8,11,14,17,20-heptone
organooxygen compound > carboxamide > peptide > (3r,6r,9s,12r,15r)-3-(1h-indol-3-ylmethyl)-15-(2-methylpropyl)-6,9,12-tri(propan-2-yl)-1,4,7,10,13,16,19-heptazacyclodocosane-2,5,8,11,14,17,20-heptone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > amide > primary amide > carboxamide > peptide > (3r,6r,9s,12r,15r)-3-(1h-indol-3-ylmethyl)-15-(2-methylpropyl)-6,9,12-tri(propan-2-yl)-1,4,7,10,13,16,19-heptazacyclodocosane-2,5,8,11,14,17,20-heptone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic amino compound > peptide > (3r,6r,9s,12r,15r)-3-(1h-indol-3-ylmethyl)-15-(2-methylpropyl)-6,9,12-tri(propan-2-yl)-1,4,7,10,13,16,19-heptazacyclodocosane-2,5,8,11,14,17,20-heptone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > organic amino compound > peptide > (3r,6r,9s,12r,15r)-3-(1h-indol-3-ylmethyl)-15-(2-methylpropyl)-6,9,12-tri(propan-2-yl)-1,4,7,10,13,16,19-heptazacyclodocosane-2,5,8,11,14,17,20-heptone

Preferred term

(3r,6r,9s,12r,15r)-3-(1h-indol-3-ylmethyl)-15-(2-methylpropyl)-6,9,12-tri(propan-2-yl)-1,4,7,10,13,16,19-heptazacyclodocosane-2,5,8,11,14,17,20-heptone  

Type

  • http://www.irandoc.ac.ir/onto/irandoc-meta/Concept

Broader concept

charge

  • 0

formula

  • C37H56N8O7

inchi

  • InChI=1S/C37H56N8O7/c1-19(2)15-26-34(49)43-31(21(5)6)36(51)45-32(22(7)8)37(52)44-30(20(3)4)35(50)42-27(16-23-17-39-25-12-10-9-11-24(23)25)33(48)38-14-13-28(46)40-18-29(47)41-26/h9-12,17,19-22,26-27,30-32,39H,13-16,18H2,1-8H3,(H,38,48)(H,40,46)(H,41,47)(H,42,50)(H,43,49)(H,44,52)(H,45,51)/t26-,27-,30-,31-,32+/m1/s1

inchikey

  • RRNVLHPABYDFDH-WFNWFSMGSA-N

mass

  • 724.904

monoisotopicmass

  • 724.42720

smiles

  • O=C1N[C@@H](C(=O)N[C@@H](C(=O)NCCC(=O)NCC(N[C@@H](C(N[C@@H](C(N[C@H]1C(C)C)=O)C(C)C)=O)CC(C)C)=O)CC=2C3=C(C=CC=C3)NC2)C(C)C

subset

  • 2_STAR

synonym EXACT

  • (3R,6R,9S,12R,15R)-3-(1H-indol-3-ylmethyl)-15-(2-methylpropyl)-6,9,12-tri(propan-2-yl)-1,4,7,10,13,16,19-heptazacyclodocosane-2,5,8,11,14,17,20-heptone

URI

http://www.irandoc.acir/onto/irandoc/CHEBI:227162

Download this concept: